昊帆生物
(301393)
| 流通市值：11.95亿 | | | 总市值：52.20亿 |
| 流通股本：2472.75万 | | | 总股本：1.08亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 91,229,728.71 | 388,794,947.08 | 303,638,966.94 | 210,102,576.45 |
| 营业收入 | 91,229,728.71 | 388,794,947.08 | 303,638,966.94 | 210,102,576.45 |
| 二、营业总成本 | 61,494,588.69 | 278,567,768.72 | 219,999,151.53 | 144,077,958.8 |
| 营业成本 | 56,531,270.9 | 238,901,601.25 | 182,973,935.82 | 119,682,874.17 |
| 税金及附加 | 600,805.24 | 2,534,550.13 | 1,581,238.54 | 1,005,633.96 |
| 销售费用 | 2,182,431.61 | 11,953,266.28 | 9,462,994.26 | 4,967,061.62 |
| 管理费用 | 5,731,275.77 | 24,014,515.35 | 16,942,127.66 | 9,083,174.54 |
| 研发费用 | 10,389,895.99 | 28,474,913.58 | 20,108,005.62 | 11,359,668.71 |
| 财务费用 | -13,941,090.82 | -27,311,077.87 | -11,069,150.37 | -2,020,454.2 |
| 其中:利息费用 | 16,356.33 | 45,270.77 | 20,693.35 | 23,415.27 |
| 其中:利息收入 | 12,439,672.85 | 27,497,756.52 | 7,365,380.74 | 380,224.91 |
| 加:公允价值变动收益 | 277,995.89 | 224,295.89 | 2,965,416.43 | - |
| 加:投资收益 | - | 1,509,192.19 | 1,509,192.22 | 842,484.81 |
| 资产处置收益 | - | -129.48 | - | - |
| 资产减值损失(新) | 634,404.65 | -4,533,662.8 | -969,375.75 | -896,313.47 |
| 信用减值损失(新) | -1,253,202.7 | -560,202.28 | -756,491.85 | -976,257.01 |
| 其他收益 | 4,774,574.41 | 5,695,511.36 | 3,638,540.83 | 2,939,224.36 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 34,168,912.27 | 112,562,183.24 | 90,027,097.29 | 67,933,756.34 |
| 加:营业外收入 | 101,495.01 | 29,197.74 | 13,340.61 | 11,090.17 |
| 减:营业外支出 | 41,247.5 | 105,515.45 | 45 | - |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 34,229,159.78 | 112,485,865.53 | 90,040,392.9 | 67,944,846.51 |
| 减:所得税费用 | 4,400,320.04 | 13,512,111 | 11,140,489.04 | 9,207,191.9 |
| 六、净利润 | 29,828,839.74 | 98,973,754.53 | 78,899,903.86 | 58,737,654.61 |
| 持续经营净利润 | 29,828,839.74 | 98,973,754.53 | 78,899,903.86 | 58,737,654.61 |
| 归属于母公司股东的净利润 | 29,828,839.74 | 98,973,754.53 | 78,899,903.86 | 58,737,654.61 |
| (一)基本每股收益 | 0.28 | 1.07 | 0.91 | 0.73 |
| (二)稀释每股收益 | 0.28 | 1.07 | 0.91 | 0.73 |
| 九、综合收益总额 | 29,828,839.74 | 98,973,754.53 | 78,899,903.86 | 58,737,654.61 |
| 归属于母公司股东的综合收益总额 | 29,828,839.74 | 98,973,754.53 | 78,899,903.86 | 58,737,654.61 |
| 公告日期 | 2024-04-26 | 2024-04-09 | 2023-10-25 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |